Stemline Therapeutics Inc. (STML)

10.20
0.46 4.70
NASDAQ : Health Technology
Prev Close 9.74
Open 9.79
Day Low/High 9.75 / 10.22
52 Wk Low/High 7.82 / 18.22
Volume 488.10K
Avg Volume 623.50K
Exchange NASDAQ
Shares Outstanding 50.13M
Market Cap 496.78M
EPS -3.00
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Checking In on 2 Small Biotech Names That Had Big Quarters

Checking In on 2 Small Biotech Names That Had Big Quarters

Stemline Therapeutics and Flexion Therapeutics both saw their shares climb on positive news developments.

My Strategy for Stemline Therapeutics

"The true New Yorker secretly believes that people living anywhere else have to be, in some sense, kidding." - John Updike The market is little changed from our noon update. It has been a lackluster day of trading in front of the Fed meeting. Not do...

Trial Patient Dies From a Stemline SL-401 Side Effect

Trial Patient Dies From a Stemline SL-401 Side Effect

A trial patient died from a Stemline Therapeutics' SL-401 cancer drug side effect, the family confirmed.

Small IPOs Bring Risks

Small IPOs Bring Risks

Gladstone Land, KaloBios Pharmaceuticals and Stemline Therapeutics plan to go public, IPO Desktop President Francis Gaskins isn't sure the risk is worth it.

Medical IPOs: Globus Medical, Stemline

Medical IPOs: Globus Medical, Stemline

IPO Desktop President Francis Gaskins likes Globus Medical, but is content to wait for Stemline.